Search results
Brookfield cancer patient gets ‘a second chance on life’ with stem cells from a Canadian athlete
The News-Times· 1 day agoSubmission of a sample to a national donor program sparked an unexpected connection between a...
Critical Mass With Law.com’s Amanda Bronstad: Why the Plaintiffs’ Bar is Roiled Over This Ballot...
Law.com· 5 hours agoThis week: A Nevada ballot proposal financed by Uber would cap contingency fees at 20% for all civil...
Danbury High runner who was on death bed with cancer graduates from Sacred Heart: 'Very determined'
The News-Times· 4 days agoIn May 2019, 21-year-old Alex Chakar was diagnosed with acute myeloid leukemia and within a few...
Udenyca: Side effects and what to do about them
Medical News Today· 5 days agoUdenyca is a prescription drug used to help prevent infection with chemotherapy. Learn about the serious side effects it can cause and how to manage...
Innate Pharma Highlights Abstracts Selected for EHA 2024 Congress - Innate Pharma (NASDAQ:IPHA)
Benzinga· 13 hours agoTwo abstracts on SAR443579 (IPH6101), ANKET® platform lead asset, a trifunctional anti-CD123 NKp46xCD16 NK cell engager under development by partner Sanofi in blood cancer Two abstracts on IPH6501, Innate's
Red carpet with a cause: This fashion show fundraiser helps kids with cancer
The Record· 6 days agoIt is now a life purpose for Paula Corrieri, of Wayne, whose 15-year-old son, Rocco Sivolella, died...
Aptose Reports Results for the First Quarter 2024
Digital Journal· 22 hours agoTUS+VEN+HMA Triplet Protocol in 1L Therapy for Newly Diagnosed AML was Submitted to the FDA During Q1 and is Now Being Activated at Clinical Sites TUS+VEN+HMA Triplet 1L Therapy for Newly Diagnosed ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 2 days agoHONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., May 14, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated a registrational Phase III clinical trial of HMPL-306
Philadelphia jury awards former mechanic $725.5M in Exxon Mobil case
Philly.com· 5 days agoA Philadelphia jury sided against Exxon Mobil Corp. and awarded $725.5 million on Thursday to a...
Analysts Set Affimed (NASDAQ:AFMD) PT at $45.00
ETF DAILY NEWS· 7 days agoShares of Affimed (NASDAQ:AFMD – Get Free Report) have been assigned an average rating of “Buy” from the five analysts that are currently covering the company, MarketBeat.com reports. Five research ...
